People feel better on your therapy.
Prove it with Folia.
Over the past 9 years, we’ve shown that, although it seems hard, you can measure your therapy against the concepts that matter most to patients and clinicians, at scale.
Bring your therapy’s impact into focus
Start with a 30-minute intro call and discover how Folia can help demonstrate your therapy’s impact on patients.
Home-reported evidence moves the market.
Folia captures what patients experience day to day, starting with the outcomes they name themselves, then tracking change over time.
Start with what patients say matters most: Participants surface symptoms and daily impacts that define the condition for them, so what you measure is already meaningful to the people living with it.
Measure within patient change: Patient-level data on the real-world impact of treatment and disease burden. The analysis heterogeneous and rare populations actually require.
Catch what happens between visits: Flares, key events, and changes recorded as they occur, not recalled months later at the next appointment.
Explain treatment behavior: Missed doses, switches, and the "why not" reasons behind them, in patients’ own words
Complement your existing strategy: Folia runs alongside validated PROs, and every partnership is built toward an abstract or manuscript your team owns.
Major partners have generated evidence with Folia across nephrology, hematology, immunology, and rare disease. Studies can start small and generate publishable insights in months, not years.
How it works
We offer a comprehensive, end-to-end research solution for complex, heterogeneous conditions, including:
Dedicated research and analysis team
Protocol design & approval
Multi-channel recruitment, e-consent, enrollment
Validated ePRO deployment that complements HROs
Data stewardship & hosting
Linkage to EMR, claims, wearables, and registry data
Data analysis and reporting
Thought partnership for scientific communications and publications
Customer Perspectives
“My programs often struggle with the fact that traditional clinical endpoints do not demonstrate the full value of the therapy, and we experience a disconnect about endpoints needed for Approval vs. for Reimbursement.”
– Vice President, HEOR (Neurology Biotech)
“This gives you insight that you don’t get from PROs and does not rely on long recall period. To me, that is the interesting nuance.”
– Executive Director, WW HEOR RWD (Top 10 Pharma)
The best pharma
teams use
home-reported outcomes.
Folia Health provides partners with longitudinal, patient-reported outcomes and high-quality structured symptom and treatment reporting. We’ve partnered with life sciences companies of all sizes, from small biotechs to top-10 pharma companies, to enhance their evidence strategy with our unique Home-Reported Outcomes (HROs) and flare diaries.
Fill out the form to schedule a time with our team. Let’s show the world the true impact of your therapy.